Second, in our patient-derived organoid cultures, we used CD45+ immune cells and the CD31+ vascular endothelial cells, which did not allow us to evaluate the contribution of each cell type to tumor cell growth and response to therapy separately. Here, PTPRC is linked to neoplasm.